Toray to focus on dialysers and catheters:
This article was originally published in Clinica
Toray Industries plans to restructure its medical device business and concentrate on dialysis systems and catheters, reports Japan Chemical Week. Toray withdrew from the clinical reagents market with the dissolving of its joint venture with Fujirebio, Toray-Fuji Bionics in April (see Clinica No 700/701, p 21). The Japanese company also intends to withdraw from the lithotripter business in the near future. It hopes the shift of focus will boost its share of the Japanese dialysis equipment market from the current level of 20%.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Alpha Source hired a new CEO from Mayline, while Mölnlycke’s CEO comes from CellaVision; Xvivo Perfusion finance chief changed job to become chief operating officer; Shire senior VP now COO at AVITA; and more.
Our updated graphic tracker of key developments from the leading vaccine candidates.